APO RESEARCH · REPORT
Transcranial Magnetic Stimulators (TMS)
Transcranial magnetic stimulation (TMS) is a magnetic method used to stimulate small regions of the brain. During a TMS procedure, a magnetic field generator, or "coil", is placed near the head of the person receiving the Tinnitus. The coil produces small electric currents in the region of the brain just under the coil via electromagnetic induction. The coil is connected to a pulse generator, or stimulator, that delivers electric current to the coil.
Product & engineering
Understand the product.
Transcranial magnetic stimulation (TMS) is a magnetic method used to stimulate small regions of the brain. During a TMS procedure, a magnetic field generator, or "coil", is placed near the head of the person receiving the Tinnitus. The coil produces small electric currents in the region of the brain just under the coil via electromagnetic induction. The coil is connected to a pulse generator, or stimulator, that delivers electric current to the coil.
TMS is used diagnostically to measure the connection between the brain and a muscle to evaluate damage from stroke, multiple sclerosis, amyotrophic lateral sclerosis, movement disorders, motor neuron disease, and injuries and other disorders affecting the facial and other cranial nerves and the spinal cord.
Selected research
Market Outlook & Growth Opportunities
Global Transcranial Magnetic Stimulators (TMS) Market Outlook and Growth Opportunities 2026
Market perspective
Transcranial magnetic stimulation (TMS) is a magnetic method used to stimulate small regions of the brain. During a TMS procedure, a magnetic field generator, or "coil", is placed near the head of the person receiving the Tinnitus. The coil produces small electric currents in the region of the brain just under the coil via electromagnetic induction. The coil is connected to a pulse generator, or stimulator, that delivers electric current to the coil.
TMS is used diagnostically to measure the connection between the brain and a muscle to evaluate damage from stroke, multiple sclerosis, amyotrophic lateral sclerosis, movement disorders, motor neuron disease, and injuries and other disorders affecting the facial and other cranial nerves and the spinal cord.
The main consumption market for TMS is China, accounting for about 50% of the market, followed by Europe, accounting for about 25%.
Read the full market overview
Leading vendors include Yiruide, Neuronetics, Magstim, Brainsway, MagVenture, and Eneura, with the top 5 accounting for about 63% of the market.
This report provides an overview of the global Transcranial Magnetic Stimulators (TMS) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Transcranial Magnetic Stimulators (TMS) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Transcranial Magnetic Stimulators (TMS) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transcranial Magnetic Stimulators (TMS) market size, projected growth trends, production technologies, key applications, and end-use industries.
Transcranial Magnetic Stimulators (TMS) Segment by Company
Yiruide
Neuronetics
Magstim
Brainsway
MagVenture
eNeura
Remed
Neurosoft
Dr. Langer Medical
Nexstim
MAG & More
EB Neuro
Jiangxi Brain Modulate Technology Development Co., LTD
VISHEE
YINGCHI
Sichuan Junjian Wanfeng Medical Devices Co., Ltd.
Transcranial Magnetic Stimulators (TMS) Segment by Type
sTMS
pTMS
rTMS
Transcranial Magnetic Stimulators (TMS) Segment by Application
Psychopharmacology
Neurology
Rehabilitation Department
Others
Transcranial Magnetic Stimulators (TMS) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Transcranial Magnetic Stimulators (TMS) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Transcranial Magnetic Stimulators (TMS) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Transcranial Magnetic Stimulators (TMS) significant trends, drivers, influence factors in global and regions.
6. To analyze Transcranial Magnetic Stimulators (TMS) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcranial Magnetic Stimulators (TMS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transcranial Magnetic Stimulators (TMS) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcranial Magnetic Stimulators (TMS).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Transcranial Magnetic Stimulators (TMS) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transcranial Magnetic Stimulators (TMS) industry.
Chapter 3: Detailed analysis of Transcranial Magnetic Stimulators (TMS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Transcranial Magnetic Stimulators (TMS) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Transcranial Magnetic Stimulators (TMS) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- sTMS
- pTMS
- rTMS
Applications
- Psychopharmacology
- Neurology
- Rehabilitation Department
- Others
Companies covered
- Yiruide
- Neuronetics
- Magstim
- Brainsway
- MagVenture
- eNeura
- Remed
- Neurosoft
- Dr. Langer Medical
- Nexstim
- MAG & More
- EB Neuro
- Jiangxi Brain Modulate Technology Development Co., LTD
- VISHEE
- YINGCHI
- Sichuan Junjian Wanfeng Medical Devices Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032)
- 1.2.2 Global Transcranial Magnetic Stimulators (TMS) Sales Volume (2021-2032)
- 1.2.3 Global Transcranial Magnetic Stimulators (TMS) Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Transcranial Magnetic Stimulators (TMS) Market Dynamics
- 2.1 Transcranial Magnetic Stimulators (TMS) Industry Trends
- 2.2 Transcranial Magnetic Stimulators (TMS) Industry Drivers
- 2.3 Transcranial Magnetic Stimulators (TMS) Industry Opportunities and Challenges
- 2.4 Transcranial Magnetic Stimulators (TMS) Industry Restraints
3 Transcranial Magnetic Stimulators (TMS) Market by Company
- 3.1 Global Transcranial Magnetic Stimulators (TMS) Company Revenue Ranking in 2025
- 3.2 Global Transcranial Magnetic Stimulators (TMS) Revenue by Company (2021-2026)
- 3.3 Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Company (2021-2026)
- 3.4 Global Transcranial Magnetic Stimulators (TMS) Average Price by Company (2021-2026)
- 3.5 Global Transcranial Magnetic Stimulators (TMS) Company Ranking (2024-2026)
- 3.6 Global Transcranial Magnetic Stimulators (TMS) Company Manufacturing Base and Headquarters
- 3.7 Global Transcranial Magnetic Stimulators (TMS) Company Product Type and Application
- 3.8 Global Transcranial Magnetic Stimulators (TMS) Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Transcranial Magnetic Stimulators (TMS) Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Transcranial Magnetic Stimulators (TMS) Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Transcranial Magnetic Stimulators (TMS) Market by Type
- 4.1 Transcranial Magnetic Stimulators (TMS) Type Introduction
- 4.1.1 sTMS
- 4.1.2 pTMS
- 4.1.3 rTMS
- 4.2 Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Type
- 4.2.1 Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Type (2021-2032)
- 4.2.3 Global Transcranial Magnetic Stimulators (TMS) Sales Volume Share by Type (2021-2032)
- 4.3 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Type
- 4.3.1 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Type (2021-2032)
- 4.3.3 Global Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type (2021-2032)
5 Transcranial Magnetic Stimulators (TMS) Market by Application
- 5.1 Transcranial Magnetic Stimulators (TMS) Application Introduction
- 5.1.1 Psychopharmacology
- 5.1.2 Neurology
- 5.1.3 Rehabilitation Department
- 5.1.4 Others
- 5.2 Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Application
- 5.2.1 Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Application (2021-2032)
- 5.2.3 Global Transcranial Magnetic Stimulators (TMS) Sales Volume Share by Application (2021-2032)
- 5.3 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Application
- 5.3.1 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Application (2021-2032)
- 5.3.3 Global Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application (2021-2032)
6 Transcranial Magnetic Stimulators (TMS) Regional Sales and Value Analysis
- 6.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Transcranial Magnetic Stimulators (TMS) Sales by Region (2021-2032)
- 6.2.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Region: 2021-2026
- 6.2.2 Global Transcranial Magnetic Stimulators (TMS) Sales by Region (2027-2032)
- 6.3 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Region (2021-2032)
- 6.4.1 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Region: 2021-2026
- 6.4.2 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Region (2027-2032)
- 6.5 Global Transcranial Magnetic Stimulators (TMS) Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032)
- 6.6.2 North America Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032)
- 6.7.2 Europe Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032)
- 6.9.2 South America Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country, 2025 VS 2032
7 Transcranial Magnetic Stimulators (TMS) Country-level Sales and Value Analysis
- 7.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Transcranial Magnetic Stimulators (TMS) Sales by Country (2021-2032)
- 7.3.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Country (2021-2026)
- 7.3.2 Global Transcranial Magnetic Stimulators (TMS) Sales by Country (2027-2032)
- 7.4 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Country (2021-2032)
- 7.4.1 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Country (2021-2026)
- 7.4.2 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.9.2 France Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.16.2 China Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.19.2 India Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Yiruide
- 8.1.1 Yiruide Company Information
- 8.1.2 Yiruide Business Overview
- 8.1.3 Yiruide Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Yiruide Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.1.5 Yiruide Recent Developments
- 8.2 Neuronetics
- 8.2.1 Neuronetics Company Information
- 8.2.2 Neuronetics Business Overview
- 8.2.3 Neuronetics Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Neuronetics Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.2.5 Neuronetics Recent Developments
- 8.3 Magstim
- 8.3.1 Magstim Company Information
- 8.3.2 Magstim Business Overview
- 8.3.3 Magstim Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Magstim Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.3.5 Magstim Recent Developments
- 8.4 Brainsway
- 8.4.1 Brainsway Company Information
- 8.4.2 Brainsway Business Overview
- 8.4.3 Brainsway Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Brainsway Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.4.5 Brainsway Recent Developments
- 8.5 MagVenture
- 8.5.1 MagVenture Company Information
- 8.5.2 MagVenture Business Overview
- 8.5.3 MagVenture Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.5.4 MagVenture Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.5.5 MagVenture Recent Developments
- 8.6 eNeura
- 8.6.1 eNeura Company Information
- 8.6.2 eNeura Business Overview
- 8.6.3 eNeura Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.6.4 eNeura Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.6.5 eNeura Recent Developments
- 8.7 Remed
- 8.7.1 Remed Company Information
- 8.7.2 Remed Business Overview
- 8.7.3 Remed Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Remed Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.7.5 Remed Recent Developments
- 8.8 Neurosoft
- 8.8.1 Neurosoft Company Information
- 8.8.2 Neurosoft Business Overview
- 8.8.3 Neurosoft Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Neurosoft Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.8.5 Neurosoft Recent Developments
- 8.9 Dr. Langer Medical
- 8.9.1 Dr. Langer Medical Company Information
- 8.9.2 Dr. Langer Medical Business Overview
- 8.9.3 Dr. Langer Medical Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Dr. Langer Medical Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.9.5 Dr. Langer Medical Recent Developments
- 8.10 Nexstim
- 8.10.1 Nexstim Company Information
- 8.10.2 Nexstim Business Overview
- 8.10.3 Nexstim Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Nexstim Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.10.5 Nexstim Recent Developments
- 8.11 MAG & More
- 8.11.1 MAG & More Company Information
- 8.11.2 MAG & More Business Overview
- 8.11.3 MAG & More Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.11.4 MAG & More Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.11.5 MAG & More Recent Developments
- 8.12 EB Neuro
- 8.12.1 EB Neuro Company Information
- 8.12.2 EB Neuro Business Overview
- 8.12.3 EB Neuro Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.12.4 EB Neuro Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.12.5 EB Neuro Recent Developments
- 8.13 Jiangxi Brain Modulate Technology Development Co., LTD
- 8.13.1 Jiangxi Brain Modulate Technology Development Co., LTD Company Information
- 8.13.2 Jiangxi Brain Modulate Technology Development Co., LTD Business Overview
- 8.13.3 Jiangxi Brain Modulate Technology Development Co., LTD Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Jiangxi Brain Modulate Technology Development Co., LTD Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.13.5 Jiangxi Brain Modulate Technology Development Co., LTD Recent Developments
- 8.14 VISHEE
- 8.14.1 VISHEE Company Information
- 8.14.2 VISHEE Business Overview
- 8.14.3 VISHEE Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.14.4 VISHEE Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.14.5 VISHEE Recent Developments
- 8.15 YINGCHI
- 8.15.1 YINGCHI Company Information
- 8.15.2 YINGCHI Business Overview
- 8.15.3 YINGCHI Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.15.4 YINGCHI Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.15.5 YINGCHI Recent Developments
- 8.16 Sichuan Junjian Wanfeng Medical Devices Co., Ltd.
- 8.16.1 Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Company Information
- 8.16.2 Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Business Overview
- 8.16.3 Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Transcranial Magnetic Stimulators (TMS) Product Portfolio
- 8.16.5 Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Transcranial Magnetic Stimulators (TMS) Value Chain Analysis
- 9.1.1 Transcranial Magnetic Stimulators (TMS) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Transcranial Magnetic Stimulators (TMS) Sales Mode & Process
- 9.2 Transcranial Magnetic Stimulators (TMS) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Transcranial Magnetic Stimulators (TMS) Distributors
- 9.2.3 Transcranial Magnetic Stimulators (TMS) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst